We are live on ! Find out more
APGNW

Apexigen, Inc. WarrantApexigen, Inc. Warrant

Delisted

APGNW was delisted on the 22nd of August, 2023.

1 hedge funds and large institutions have $1.49K invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less capital invested

Capital invested by funds: $24.6K → $1.49K (-$23.1K)

95% less funds holding

Funds holding: 191 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 18

Holders
1
Holders Change
-18
Holders Change %
-94.74%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
18
Calls
Puts
Net Calls
Net Calls Change

APGNW Hedge Fund Activity: Q3 2023 in Review

1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q3 2023, worth a combined $1.49K — down 94% from $24.6K a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of APGNW and 0 opened new positions — a net loss of 18 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Kepos Capital, exiting entirely with an estimated $5K sold.

  • 1 institutional investor held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q3 2023, down from 19 in Q2 2023.
  • Funds reported $1.49K of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q3 2023, down 94% quarter-over-quarter.
  • 0 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q3 2023 and 18 closed out, a net change of -18 holders.
  • The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant seller in Q3 2023 was Kepos Capital, an estimated $5K sold.

Based on aggregated 13F filings for Q3 2023.